Parkinson's Disease
Conference Coverage
DBS provides long-term benefits for patients with Parkinson’s disease
LAS VEGAS – A large-scale collection of outcomes suggests that DBS offers sustained improvement of motor and nonmotor symptoms.
Literature Review
No evidence for disease-modifying effect of levodopa in Parkinson’s disease
In the LEAP study, patients with early Parkinson’s disease who were treated with levodopa in combination with carbidopa showed no disease-...
From the Journals
Nuedexta mainly prescribed for dementia, Parkinson’s
Only 15.2% of patients had multiple sclerosis or amyotrophic lateral sclerosis, the diagnoses of patients in the studies leading to the approval...
Literature Review
Neurologic Disease Eventually Affects Half of Women and One-Third of Men
Around one-half of women and one-third of men will develop dementia, stroke, or parkinsonism during their lifetime,...
From the Journals
New brain circuitry found with Parkinson’s disease gene therapy
Imaging has revealed the formation of new brain circuitry in patients with Parkinson’s disease treated with gene therapy.
News
Appendix linked to Parkinson’s disease in series of unexpected findings
Appendectomy reduces PD risk by about 20%.
Conference Coverage
Parkinson’s prevalence varies significantly from state to state
ATLANTA – Findings can be used to inform planning at the state and federal levels.
Conference Coverage
Can boxing training improve Parkinson reaction times?
NEW YORK – Program tries to help slow the decline or maintain a level of functioning in Parkinson’s disease.
Conference Coverage
Investigational gene therapy for medically refractory Parkinson’s shows promise
ATLANTA – A randomized, double-blind, placebo surgery–controlled trial of VY-AADC01 is currently recruiting subjects.
Conference Coverage
Novel imaging may differentiate dementia in Parkinson’s
NEW YORK – A neuroimaging technique uses positron emission tomography to differentiate between dementia in Alzheimer’s disease from that in...
Conference Coverage
Antiepileptic drug shows neuroprotection in Parkinson’s
NEW YORK – Early research has shown that the antiepileptic drug valproic acid may improve nerve function in PD and complement levodopa.